[Hepatitis-A vaccination in children]

D Gendrel1

  • 1Hôpital Saint Vincent de Paul, Paris, France. dominique.gendrel@svp.ap-hop-paris.fr

Insights

Hepatitis A vaccination is recommended for children traveling to endemic areas. Early childhood immunization offers durable protection and can prevent family-wide outbreaks, even in young children.

Area of Science:

  • Hepatitis A epidemiology
  • Vaccinology
  • Public health

Context:

  • Hepatitis A vaccination is recommended in France for specific pediatric groups, including those in healthcare settings, with chronic liver disease, or traveling to endemic regions.
  • Asymptomatic children under 5 years old can transmit Hepatitis A, posing a risk to family members and communities.
  • Current French recommendations focus on travel, but post-exposure prophylaxis is a significant concern.

Purpose:

  • To evaluate the effectiveness and tolerability of early childhood Hepatitis A vaccination for preventing transmission within families and closed communities.
  • To highlight the need for recognizing post-exposure prophylaxis as a key indication for Hepatitis A vaccination in France.
  • To inform pediatricians about the risks of Hepatitis A in children and the benefits of timely family prophylaxis.

Summary:

  • Hepatitis A vaccination in early childhood provides long-lasting protection and is crucial for children traveling to endemic areas, preventing secondary infections within families.
  • While routine vaccination is no longer needed in France due to decreased incidence, immediate post-exposure vaccination (within 7 days) is effective for prophylaxis around index cases in families and communities.
  • Despite positive trial results and recommendations from other countries, this post-exposure indication is not officially recognized in France, necessitating pediatrician advocacy for family protection.

Impact:

  • Early and potentially lifelong protection against Hepatitis A for children and their families.
  • Effective control of localized outbreaks and prevention of severe secondary infections.
  • Potential to influence public health policy regarding Hepatitis A vaccination indications in France.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Vaccinations01:51

Vaccinations

Overview
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...